Thiard News@F4F

@newsen.bsky.social

1 month ago

DOMA Perpetual Moves to Reshape Pacira BioSciences' Board with New Nominations Amidst Stock Struggles Amid a concerning decline in stock performance, DOMA Perpetual Capital Management has nominated three candidates for Pacira BioSciences' Board, aiming for strategic change.

DOMA Perpetual Moves to Reshape Pacira BioSciences' Board with New Nominations Amidst Stock Struggles #USA #Miami #Pacira_BioSciences #DOMA_Perpetual #Frank_Lee

Thiard News@F4F

@newsen.bsky.social

1 month ago

DOMA Perpetual Proposes New Directors Amidst Pacira's Troubling Performance and Stock Downtrend DOMA Perpetual has nominated three highly skilled candidates for Pacira BioSciences' Board to reverse a decade-long stock decline and enhance management oversight.

DOMA Perpetual Proposes New Directors Amidst Pacira's Troubling Performance and Stock Downtrend #United_States #Miami #Pacira_BioSciences #DOMA_Perpetual #Frank_Lee

Thiard News@F4F

@newsen.bsky.social

2 months ago

AmacaThera Recognized as Ontario's Life Sciences Rising Star for 2026 AmacaThera has been named Life Sciences Ontario Emerging Company of the Year, marking a significant achievement in drug delivery innovation and partnership.

AmacaThera Recognized as Ontario's Life Sciences Rising Star for 2026 #Canada #Toronto #Pacira_BioSciences #Hydrogel #AmacaThera

Thiard News@F4F

@newsen.bsky.social

3 months ago

DOMA Perpetual Capital Management Plans to Nominate New Directors for Pacira BioSciences at 2026 Meeting DOMA Perpetual Capital Management announces its intention to nominate three independent director candidates for Pacira BioSciences at the 2026 annual meeting.

DOMA Perpetual Capital Management Plans to Nominate New Directors for Pacira BioSciences at 2026 Meeting #USA #Miami #Board_of_Directors #Pacira_BioSciences #DOMA_Capital

Thiard News@F4F

@newsen.bsky.social

5 months ago

DOMA Perpetual Calls for Immediate Sale Exploration of Pacira BioSciences DOMA Perpetual Capital Management has urged Pacira BioSciences' board to hire bankers and explore a sale process, citing poor performance and excessive spending.

DOMA Perpetual Calls for Immediate Sale Exploration of Pacira BioSciences #USA #Miami #Pacira_BioSciences #Exparel #DOMA_Perpetual

Thiard News@F4F

@newsen.bsky.social

5 months ago

AmacaThera and Pacira BioSciences Forge Major Licensing Deal for AMT-143, Valued at Up to $230 Million AmacaThera has secured a monumental licensing agreement with Pacira BioSciences, worth up to $230 million, to advance AMT-143, a non-opioid solution for post-operative pain management.

AmacaThera and Pacira BioSciences Forge Major Licensing Deal for AMT-143, Valued at Up to $230 Million #Canada #Toronto #Pacira_BioSciences #AmacaThera #AMT-143

Thiard News@F4F

@newsen.bsky.social

9 months ago

Legal Action Looms for Investors of Pacira BioSciences, Inc. Amid Patent Controversy Investors in Pacira BioSciences, Inc. (NASDAQ: PCRX) who incurred losses are urged to connect with the Shareholders Foundation regarding an ongoing lawsuit concerning patent claims.

Legal Action Looms for Investors of Pacira BioSciences, Inc. Amid Patent Controversy #United_States #San_Diego #Inc. #Shareholders_Foundation #Pacira_BioSciences #NASDAQ_PCRX

Thiard News@F4F

@newsen.bsky.social

11 months ago

Shareholders Foundation Announces Lawsuit for Pacira BioSciences, Inc. Investors Amid Patent Controversies A lawsuit has been filed against Pacira BioSciences, Inc. by investors following troubling revelations regarding patent protections for Exparel, vital for the company's growth.

Shareholders Foundation Announces Lawsuit for Pacira BioSciences, Inc. Investors Amid Patent Controversies #United_States #San_Diego #Securities_Law #Pacira_BioSciences #Exparel

Thiard News@F4F

@newsen.bsky.social

11 months ago

DOMA Perpetual Endorses Pacira's $300 Million Share Buyback as a Strategic Move for Shareholder Returns DOMA Perpetual has expressed strong support for Pacira's new $300 million share repurchase authorization, aiming to bolster shareholder value through strategic financial measures.

DOMA Perpetual Endorses Pacira's $300 Million Share Buyback as a Strategic Move for Shareholder Returns #USA #Miami #stock_buyback #Pacira_BioSciences #DOMA_Perpetual

Thiard News@F4F

@newsen.bsky.social

1 year ago

DOMA Perpetual Proposes New Leadership for Pacira BioSciences Board to Combat Declining Stock Value DOMA Perpetual has nominated three candidates for the Pacira BioSciences board, aiming to reverse a decade of stock performance decline and enhance shareholder value.

DOMA Perpetual Proposes New Leadership for Pacira BioSciences Board to Combat Declining Stock Value #USA #Miami #Pacira_BioSciences #DOMA_Perpetual #Stock_Performance

Thiard News@F4F

@newsen.bsky.social

1 year ago

Class Action Lawsuit Filed Against Pacira BioSciences, Investors Urged to Join by March 14, 2025 Levi & Korsinsky announces a class action lawsuit against Pacira BioSciences, urging affected investors to join by the March 14, 2025 deadline.

Class Action Lawsuit Filed Against Pacira BioSciences, Investors Urged to Join by March 14, 2025 #United_States #New_York #Class_Action #Securities_Fraud #Pacira_BioSciences

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pomerantz Law Firm Issues Investor Alert Regarding Pacira Biosciences, Class Action Filed Pomerantz Law Firm has announced a class action lawsuit against Pacira Biosciences, Inc. Investors affected should act before the deadline.

Pomerantz Law Firm Issues Investor Alert Regarding Pacira Biosciences, Class Action Filed #United_States #New_York #Securities_Fraud #Pomerantz_Law_Firm #Pacira_BioSciences

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pacira BioSciences Investors Advised to Join Class Action Over Stock Losses Following Patent Challenges The Gross Law Firm announces an important class action for Pacira BioSciences investors. Shareholders affected by the stock drop are urged to register.

Pacira BioSciences Investors Advised to Join Class Action Over Stock Losses Following Patent Challenges #United_States #New_York #Class_Action #Gross_Law_Firm #Pacira_BioSciences

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pacira BioSciences Faces Class Action Lawsuit: ClaimsFiler Alerts Investors of Deadline Investors with losses exceeding $100,000 in Pacira BioSciences are warned about the upcoming deadline to file lead plaintiff applications in a class action lawsuit.

Pacira BioSciences Faces Class Action Lawsuit: ClaimsFiler Alerts Investors of Deadline #USA #Class_Action #New_Orleans #ClaimsFiler #Pacira_BioSciences

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pacira BioSciences, Inc. Shareholders Alerted About Class Action Lawsuit and Important Deadline The Gross Law Firm informs Pacira BioSciences shareholders about a class action lawsuit over patent infringement. Register now to participate.

Pacira BioSciences, Inc. Shareholders Alerted About Class Action Lawsuit and Important Deadline #United_States #New_York #Gross_Law_Firm #Pacira_BioSciences #PCRX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Investors Advised to Seek Legal Assistance Amid Pacira BioSciences' Patent Turmoil Faruqi & Faruqi, LLP is investigating potential claims for investors in Pacira BioSciences, focusing on recent setbacks regarding patent disputes.

Investors Advised to Seek Legal Assistance Amid Pacira BioSciences' Patent Turmoil #USA #New_York #Faruqi_&_Faruqi #Pacira_BioSciences #NASDAQ_PCRX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pacira BioSciences Securities Fraud Lawsuit Deadline Approaches: Investors Can Lead the Charge Investors in Pacira BioSciences, Inc. have a crucial opportunity to join a securities fraud lawsuit. The deadline to act is March 14, 2025.

Pacira BioSciences Securities Fraud Lawsuit Deadline Approaches: Investors Can Lead the Charge #United_States #New_York #Rosen_Law_Firm #Pacira_BioSciences #PCRX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Levi & Korsinsky Informs Pacira BioSciences Shareholders About Class Action Lawsuit and Deadline Levi & Korsinsky announces important details regarding a class action lawsuit against Pacira BioSciences, including critical deadlines for shareholders.

Levi & Korsinsky Informs Pacira BioSciences Shareholders About Class Action Lawsuit and Deadline #USA #New_York #Levi_&_Korsinsky #Pacira_BioSciences #PCRX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pomerantz Law Firm Issues Investor Alert on Class Action Against Pacira Biosciences, Inc. Pomerantz LLP has announced a class action lawsuit against Pacira Biosciences for alleged securities fraud. Investors have until March 14, 2025, to respond.

Pomerantz Law Firm Issues Investor Alert on Class Action Against Pacira Biosciences, Inc. #USA #New_York #Class_Action #Pomerantz_LLP #Pacira_BioSciences

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pacira BioSciences Shareholders Face Urgent Lead Plaintiff Deadline in Lawsuit The Gross Law Firm alerts Pacira shareholders of the March 14, 2025 lead plaintiff deadline in a significant lawsuit regarding patent invalidation. Immediate action is required.

Pacira BioSciences Shareholders Face Urgent Lead Plaintiff Deadline in Lawsuit #United_States #New_York #Gross_Law_Firm #Pacira_BioSciences #PCRX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Investors Urged to Act Before Deadline in Class Action Against Pacira BioSciences Kahn Swick & Foti, LLC warns investors of a crucial deadline regarding a class action lawsuit against Pacira BioSciences. Details outlined.

Investors Urged to Act Before Deadline in Class Action Against Pacira BioSciences #United_States #Kahn_Swick_&_Foti #New_Orleans #Pacira_BioSciences #Charles_C._Foti_Jr.

Thiard News@F4F

@newsen.bsky.social

1 year ago

Investors of Pacira BioSciences Targeted in Class Action Lawsuit Notification by Levi & Korsinsky Levi & Korsinsky has informed investors about a class action lawsuit against Pacira BioSciences related to alleged securities fraud and upcoming deadlines.

Investors of Pacira BioSciences Targeted in Class Action Lawsuit Notification by Levi & Korsinsky #USA #New_York #Levi_&_Korsinsky #Pacira_BioSciences #PCRX_Class_Action

Thiard News@F4F

@newsen.bsky.social

1 year ago

Important Securities Fraud Class Action Update for Pacira BioSciences Investors with Losses Over $100K Investors in Pacira BioSciences with over $100K in losses are urged to consider leading a securities fraud class action lawsuit, with significant deadlines approaching.

Important Securities Fraud Class Action Update for Pacira BioSciences Investors with Losses Over $100K #United_States #New_York #Securities_Fraud #Rosen_Law_Firm #Pacira_BioSciences

Thiard News@F4F

@newsen.bsky.social

1 year ago

Investors Affected by Pacira's Stock Plunge Urged to Act by Legal Experts Faruqi & Faruqi, LLP invites investors suffering significant losses in Pacira BioSciences stock to discuss their legal options before a critical deadline.

Investors Affected by Pacira's Stock Plunge Urged to Act by Legal Experts #USA #New_York #Faruqi_&_Faruqi #securities_litigation #Pacira_BioSciences

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pacira BioSciences Shareholders Urged to Act Over Stock Price Plunge Following Patent Case Investors in Pacira BioSciences are encouraged to contact The Gross Law Firm regarding a class action lawsuit after a significant stock price drop due to patent invalidation.

Pacira BioSciences Shareholders Urged to Act Over Stock Price Plunge Following Patent Case #USA #New_York #Class_Action #The_Gross_Law_Firm #Pacira_BioSciences

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pomerantz Law Firm Issues Warning About Class Action Lawsuit for Pacira Biosciences Investors Pomerantz LLP alerts investors about a class action lawsuit against Pacira Biosciences, Inc. concerning securities fraud and upcoming deadlines for claims.

Pomerantz Law Firm Issues Warning About Class Action Lawsuit for Pacira Biosciences Investors #USA #New_York #Pomerantz_LLP #Pacira_BioSciences #PCRX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Investors of Pacira BioSciences Can Join Class Action Against Securities Fraud Pacira BioSciences investors are urged to join a class action lawsuit over alleged securities fraud surrounding misleading statements. Join now.

Investors of Pacira BioSciences Can Join Class Action Against Securities Fraud #United_States #Los_Angeles #Schall_Law_Firm #Securities_Fraud #Pacira_BioSciences

Thiard News@F4F

@newsen.bsky.social

1 year ago

Levi & Korsinsky Alerts Pacira BioSciences Investors of Class Action Lawsuit and Deadlines Levi & Korsinsky informs Pacira BioSciences investors about a class action lawsuit regarding securities fraud and important deadlines.

Levi & Korsinsky Alerts Pacira BioSciences Investors of Class Action Lawsuit and Deadlines #United_States #New_York #Class_Action #Securities_Fraud #Pacira_BioSciences

Thiard News@F4F

@newsen.bsky.social

1 year ago

Pacira BioSciences Investors Alert: Important Class Action Lawsuit Notification and Upcoming Deadlines Investors of Pacira BioSciences, Inc. are urged to take action regarding a pending class action lawsuit with a deadline to lead by March 14, 2025.

Pacira BioSciences Investors Alert: Important Class Action Lawsuit Notification and Upcoming Deadlines #USA #New_York #Class_Action #Pacira_BioSciences #PCRX

Thiard News@F4F

@newsen.bsky.social

1 year ago

Investors of Pacira BioSciences Can Pursue Securities Fraud Class Action Lawsuit Investors who purchased Pacira BioSciences securities between August 2023 and August 2024 have the opportunity to join a class action lawsuit for potential compensation.

Investors of Pacira BioSciences Can Pursue Securities Fraud Class Action Lawsuit #USA #New_York #Rosen_Law_Firm #Fraud_Lawsuit #Pacira_BioSciences